6/20/2019 | DD | Pernix Therapeutics third amended liquidation plan confirmed by court
|
6/11/2019 | DD | Pernix Therapeutics marks $3.77 million April net gain from operations
|
4/22/2019 | DD | Pernix sale deal amended to replace $5 million credit bid with cash
|
4/15/2019 | DD | Pernix Therapeutics Holdings OK’d to sell assets to Highbridge funds
|
4/9/2019 | DD | Pernix Therapeutics cancels auction, to seek OK of stalking horse bid
|
3/22/2019 | DD | Pernix Therapeutics bid procedures approved; auction set for April 11
|
3/4/2019 | DD | Pernix Therapeutics’ official committee of unsecured creditors named
|
2/22/2019 | BKCVDDEMHY | Prospect News reports two new defaults for week of Feb. 14-Feb. 20
|
2/21/2019 | DD | Pernix Therapeutics granted access to $20.1 million of DIP financing
|
2/19/2019 | BKCVDDHY | Pernix Therapeutics files bankruptcy, gets $75.6 million lead bid
|
8/1/2018 | BK | Pernix amends asset-based revolver, delayed-draw term loan facility
|
8/1/2018 | CVHYLM | Pernix exchanges 12% notes due 2020 for stock, convertible preferreds
|
4/24/2018 | BK | Pernix Therapeutics amends ABL revolver to edit borrowing base formula
|
7/20/2017 | BKCV | Pernix refinances with new revolver, term loan, exchanges convertibles
|
12/29/2016 | CVDDHY | Pernix: Talks founder on restructuring 12% notes, 4.25% convertibles
|
5/6/2016 | DD | Market Commentary: Chesapeake gains on asset sale, oils up as prices rise amid Canada fire; Weatherford walloped
|
5/5/2016 | CV | Market Commentary: Atlas Air flies higher in heavy volume; Tesla Motors lower outright, mixed on swap
|
5/5/2016 | CV | Market Commentary: Morning Commentary: Atlas Air higher after earnings beat; Tesla Motors down outright, mixed on swap
|
3/17/2016 | CV | Market Commentary: Convertibles better in light volume; some energy names miss rally; Helix pops; Pernix drops more
|
3/15/2016 | CV | Market Commentary: Valeant woes cast a pall over convertible biotech/health care; energy shows resilience
|
4/24/2015 | HYLM | Pernix: Holders of 12% notes OK incurrence of up to $42.2 million debt
|
4/24/2015 | CV | Market Commentary: Spectranetics gains on swap after quarterly loss; new Cinedigm trades at 101 to 103
|
4/24/2015 | CV | Market Commentary: Morning Commentary: New Cinedigm convertibles trade at 101 to 103; Pernix around par
|
4/17/2015 | CVLM | Pernix holders agree to convert all $65 million 8% notes due 2019
|
4/17/2015 | PP | Market Commentary: New Pernix trades up; ServiceNow adds on swap after earnings; Mylan eyed amid merger talk
|
4/17/2015 | CV | Market Commentary: New Pernix trades up; ServiceNow adds on swap after earnings; Mylan eyed amid merger talk
|
4/17/2015 | CV | Market Commentary: Morning Commentary: New Pernix convertibles trade up; ServiceNow drops outright after earnings
|
4/17/2015 | CV | New Issue: Pernix Therapeutics sells upsized $130 million six-year convertibles at 4.25%, up 37.5%
|
4/16/2015 | PP | Market Commentary: SanDisk lower outright, edges up on swap; Teva below parity; planned Pernix looks cheap
|
4/16/2015 | CV | Market Commentary: SanDisk lower outright, edges up on swap; Teva below parity; planned Pernix looks cheap
|
4/16/2015 | CV | Market Commentary: Morning Commentary: SanDisk lower outright after disappointing earnings; Pernix deal eyed
|
4/15/2015 | PP | Market Commentary: Energy names jump with higher crude oil prices; Intel bonds mixed; Pernix to tap market
|
4/15/2015 | CV | Market Commentary: Energy names jump with higher crude oil prices; Intel bonds mixed; Pernix to tap market
|
4/15/2015 | CV | Pernix plans to price $120 million six-year convertibles to yield 3.75%-4.25%, up 27.5%-32.5%
|
4/13/2015 | HYLM | Pernix Therapeutics solicits consents to amend 12% secured notes
|
8/25/2014 | PV | New Issue: Pernix Therapeutics details $220 million note placement
|
8/20/2014 | HY | New Issue: Pernix Therapeutics prices $220 million 12% notes
|
2/26/2014 | PP | Pernix Therapeutics wraps $65 million 8% convertibles placement
|
2/5/2014 | PP | Pernix Therapeutics Holdings plans $65 million convertibles placement
|
2/10/2012 | PP | Pernix agrees to sell up to $25 million of stock from time to time
|
7/21/2011 | PP | Pernix Therapeutics prices $28 million offering of common stock
|
6/1/2011 | CVHYPF | Pernix Therapeutics files $75 million stock, debt and preferreds shelf
|